Invariant natural killer T cell agonist modulates experimental focal and segmental glomerulosclerosis

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Pereira, Rafael L ^a   Reis, Vanessa O ^a   Semedo, Patricia ^a   Buscariollo, Bruna N ^a   Donizetti Oliveira, Cassiano ^a   Cenedeze, Marcos A ^a   Soares, Maria Fernanda ^a   Pacheco Silva, Alvaro ^a,b   Savage, Paul B ^c   Câmara, Niels O S ^a,d   Keller, Alexandre C ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^c Brigham Young University   (United States)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; EOTAXIN; GANGLIOSIDE GD3; GANGLIOSIDE GD3 SYNTHASE; GANGLIOSIDE GM3; GANGLIOSIDE GM3 SYNTHASE; GLYCOLIPID; GSL 1 GLYCOLIPID; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 4; RANTES; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD7 PROTEIN; SYNTHETASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ALPHA N ACETYLNEURAMINATE ALPHA 2,8 SIALYLTRANSFERASE; ALPHA-N-ACETYLNEURAMINATE ALPHA-2,8-SIALYLTRANSFERASE; CERAMIDE; CHEMOKINE; CYTOKINE; PRIMER DNA; SIALYLTRANSFERASE; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; FOCAL GLOMERULOSCLEROSIS; KIDNEY FAILURE; KIDNEY FIBROSIS; MALE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PODOCYTE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEINURIA; RENAL PROTECTION; SPHINGOMONAS; TH1 CELL; ANALYSIS OF VARIANCE; ANIMAL; BAGG ALBINO MOUSE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; KIDNEY; METABOLISM; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TH2 CELL; WESTERN BLOTTING;

MUS; SPHINGOMONAS;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; CERAMIDES; CHEMOKINES; CYTOKINES; DNA PRIMERS; DOXORUBICIN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; KIDNEY; MALE; MICE; MICE, INBRED BALB C; NATURAL KILLER T-CELLS; REAL-TIME POLYMERASE CHAIN REACTION; SIALYLTRANSFERASES; SIGNAL TRANSDUCTION; SMAD PROTEINS; SPHINGOMONAS; TH2 CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84858056518     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032454     Document Type: Article

References (46)

1. Barisoni L, Schnaper HW, Kopp JB, (2009) Advances in the biology and genetics of the podocytopathies: implications for diagnosis and therapy. Arch Pathol Lab Med 133: 201-216.
2. Yap HK, Cheung W, Murugasu B, Sim SK, Seah CC, et al. (1999) Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse. J Am Soc Nephrol 10: 529-537.
3. Le Berre L, Herve C, Buzelin F, Usal C, Soulillou JP, et al. (2005) Renal macrophage activation and Th2 polarization precedes the development of nephrotic syndrome in Buffalo/Mna rats. Kidney Int 68: 2079-2090.
4. Lai KW, Wei CL, Tan LK, Tan PH, Chiang GS, et al. (2007) Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats. J Am Soc Nephrol 18: 1476-1485.
5. Fujii S, Shimizu K, Smith C, Bonifaz L, Steinman RM, (2003) Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J Exp Med 198: 267-279.
6. Coppieters K, Van Beneden K, Jacques P, Dewint P, Vervloet A, et al. (2007) A single early activation of invariant NK T cells confers long-term protection against collagen-induced arthritis in a ligand-specific manner. J Immunol 179: 2300-2309.
7. Hachem P, Lisbonne M, Michel ML, Diem S, Roongapinun S, et al. (2005) Alpha-galactosylceramide-induced iNKT cells suppress experimental allergic asthma in sensitized mice: role of IFN-gamma. Eur J Immunol 35: 2793-2802.
8. Matsuda H, Suda T, Sato J, Nagata T, Koide Y, et al. (2005) alpha-Galactosylceramide, a ligand of natural killer T cells, inhibits allergic airway inflammation. Am J Respir Cell Mol Biol 33: 22-31.
9. Matsuda JL, Mallevaey T, Scott-Browne J, Gapin L, (2008) CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system. Curr Opin Immunol 20: 358-368.
10. Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, et al. (1997) CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 278: 1626-1629.
11. Cerundolo V, Silk JD, Masri SH, Salio M, (2009) Harnessing invariant NKT cells in vaccination strategies. Nat Rev Immunol 9: 28-38.
12. Cerundolo V, Salio M, (2007) Harnessing NKT cells for therapeutic applications. Curr Top Microbiol Immunol 314: 325-340.
13. Long X, Deng S, Mattner J, Zang Z, Zhou D, et al. (2007) Synthesis and evaluation of stimulatory properties of Sphingomonadaceae glycolipids. Nat Chem Biol 3: 559-564.
14. Pippin JW, Brinkkoetter PT, Cormack-Aboud FC, Durvasula RV, Hauser PV, et al. (2009) Inducible rodent models of acquired podocyte diseases. Am J Physiol Renal Physiol 296: F213-229.
15. Wang Y, Wang YP, Tay YC, Harris DC, (2000) Progressive adriamycin nephropathy in mice: sequence of histologic and immunohistochemical events. Kidney Int 58: 1797-1804.
16. Amore A, Mazzucco G, Cavallo F, Forni G, Gianoglio B, et al. (1996) Adriamycin-induced proteinuria in nude mice: an immune-system-mediated toxic effect. Nephrol Dial Transplant 11: 1012-1018.
17. Cui J, Shin T, Kawano T, Sato H, Kondo E, et al. (1997) Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 278: 1623-1626.
18. Zheng W, Flavell RA, (1997) The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89: 587-596.
19. Lee GR, Fields PE, Flavell RA, (2001) Regulation of IL-4 gene expression by distal regulatory elements and GATA-3 at the chromatin level. Immunity 14: 447-459.
20. Ansel KM, Djuretic I, Tanasa B, Rao A, (2006) Regulation of Th2 differentiation and Il4 locus accessibility. Annu Rev Immunol 24: 607-656.
21. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, et al. (2000) A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100: 655-669.
22. Shimaoka T, Seino K, Kume N, Minami M, Nishime C, et al. (2007) Critical role for CXC chemokine ligand 16 (SR-PSOX) in Th1 response mediated by NKT cells. J Immunol 179: 8172-8179.
23. Li Y, Kang YS, Dai C, Kiss LP, Wen X, et al. (2008) Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. Am J Pathol 172: 299-308.
24. Pease JE, (2006) Asthma, allergy and chemokines. Curr Drug Targets 7: 3-12.
25. Lee HS, Song CY, Effects of TGF-beta on podocyte growth and disease progression in proliferative podocytopathies. Kidney Blood Press Res 33: 24-29.
26. Mesnard L, Keller AC, Michel ML, Vandermeersch S, Rafat C, et al. (2009) Invariant natural killer T cells and TGF-beta attenuate anti-GBM glomerulonephritis. J Am Soc Nephrol 20: 1282-1292.
27. Mattner J, Debord KL, Ismail N, Goff RD, Cantu C 3rd, et al. (2005) Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434: 525-529.
28. Paget C, Bialecki E, Fontaine J, Vendeville C, Mallevaey T, et al. (2009) Role of invariant NK T lymphocytes in immune responses to CpG oligodeoxynucleotides. J Immunol 182: 1846-1853.
29. Holthofer H, Reivinen J, Miettinen A, (1994) Nephron segment and cell-type specific expression of gangliosides in the developing and adult kidney. Kidney Int 45: 123-130.
30. Holthofer H, Reivinen J, Solin ML, Haltia A, Miettinen A, (1996) Decrease of glomerular disialogangliosides in puromycin nephrosis of the rat. Am J Pathol 149: 1009-1015.
31. Reivinen J, Holthofer H, Miettinen A, (1992) A cell-type specific ganglioside of glomerular podocytes in rat kidney: an O-acetylated GD3. Kidney Int 42: 624-631.
32. Simons M, Schwarz K, Kriz W, Miettinen A, Reiser J, et al. (2001) Involvement of lipid rafts in nephrin phosphorylation and organization of the glomerular slit diaphragm. Am J Pathol 159: 1069-1077.
33. Noguchi M, Kabayama K, Uemura S, Kang BW, Saito M, et al. (2006) Endogenously produced ganglioside GM3 endows etoposide and doxorubicin resistance by up-regulating Bcl-2 expression in 3LL Lewis lung carcinoma cells. Glycobiology 16: 641-650.
34. Lee VW, Harris DC, Adriamycin nephropathy: a model of focal segmental glomerulosclerosis. Nephrology (Carlton) 16: 30-38.
35. Paget C, Mallevaey T, Speak AO, Torres D, Fontaine J, et al. (2007) Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids. Immunity 27: 597-609.
36. Yoshida S, Nagase M, Shibata S, Fujita T, (2008) Podocyte injury induced by albumin overload in vivo and in vitro: involvement of TGF-beta and p38 MAPK. Nephron Exp Nephrol 108: e57-68.
37. Wu DT, Bitzer M, Ju W, Mundel P, Bottinger EP, (2005) TGF-beta concentration specifies differential signaling profiles of growth arrest/differentiation and apoptosis in podocytes. J Am Soc Nephrol 16: 3211-3221.
38. Mozes MM, Bottinger EP, Jacot TA, Kopp JB, (1999) Renal expression of fibrotic matrix proteins and of transforming growth factor-beta (TGF-beta) isoforms in TGF-beta transgenic mice. J Am Soc Nephrol 10: 271-280.
39. Park SW, Bae JS, Kim KS, Park SH, Lee BH, et al. (2004) Beta ig-h3 promotes renal proximal tubular epithelial cell adhesion, migration and proliferation through the interaction with alpha3beta1 integrin. Exp Mol Med 36: 211-219.
40. Schiffer M, Schiffer LE, Gupta A, Shaw AS, Roberts IS, et al. (2002) Inhibitory smads and tgf-Beta signaling in glomerular cells. J Am Soc Nephrol 13: 2657-2666.
41. Wang W, Huang XR, Li AG, Liu F, Li JH, et al. (2005) Signaling mechanism of TGF-beta1 in prevention of renal inflammation: role of Smad7. J Am Soc Nephrol 16: 1371-1383.
42. Zheng Z, Pavlidis P, Chua S, D'Agati VD, Gharavi AG, (2006) An ancestral haplotype defines susceptibility to doxorubicin nephropathy in the laboratory mouse. J Am Soc Nephrol 17: 1796-1800.
43. Zheng Z, Schmidt-Ott KM, Chua S, Foster KA, Frankel RZ, et al. (2005) A Mendelian locus on chromosome 16 determines susceptibility to doxorubicin nephropathy in the mouse. Proc Natl Acad Sci U S A 102: 2502-2507.
44. Mu W, Ouyang X, Agarwal A, Zhang L, Long DA, et al. (2005) IL-10 suppresses chemokines, inflammation, and fibrosis in a model of chronic renal disease. J Am Soc Nephrol 16: 3651-3660.
45. Harris RC, Neilson EG, (2006) Toward a unified theory of renal progression. Annu Rev Med 57: 365-380.
46. Zeisberg M, Kalluri R, (2004) Experimental strategies to reverse chronic renal disease. Blood Purif 22: 440-445.